Orexigen Empatic That Results For Second Obesity Drug Will Help Lure Partner
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Given the potential to cause birth defects, Orexigen's obesity drug Empatic is probably not suited for the masses. Still, executives say the promising combo pill could complement the company's better known obesity agent Contrave and help bring a partner on board